Ascendis Pharma A/S (ASND)
263.97
+2.74
(+1.05%)
USD |
NASDAQ |
Sep 11, 16:00
263.97
0.00 (0.00%)
After-Hours: 17:11
Ascendis Pharma Gross Profit (TTM) : 1.097B for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.097B |
| March 31, 2026 | 878.23M |
| December 31, 2025 | 698.12M |
| September 30, 2025 | 608.87M |
| June 30, 2025 | 436.90M |
| March 31, 2025 | 322.05M |
| December 31, 2024 | 330.41M |
| September 30, 2024 | 285.36M |
| June 30, 2024 | 277.01M |
| March 31, 2024 | 285.19M |
| December 31, 2023 | 219.52M |
| September 30, 2023 | 115.85M |
| June 30, 2023 | 85.94M |
| March 31, 2023 | 54.21M |
| December 31, 2022 | 25.95M |
| September 30, 2022 | 4.499M |
| June 30, 2022 | -4.644M |
| March 31, 2022 | -5.371M |
| December 31, 2021 | -3.315M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 2.149M |
| December 31, 2015 | 2.149M |
| September 30, 2015 | 5.511M |
| June 30, 2015 | 9.652M |
| March 31, 2015 | 7.503M |
| December 31, 2014 | 7.503M |
| September 30, 2014 | 4.142M |
| June 30, 2014 | 7.928M |
| March 31, 2014 | 7.928M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Evaxion AS | 0.00 |
| BioMarin Pharmaceutical, Inc. | 2.556B |
| Genmab A/S | 3.839B |
| Zealand Pharma A/S | 716.89M |
| Cellectis SA | 37.38M |